Alternating Cycles of Carboplatin/Gemcitabine and Carboplatin/Taxol for Advanced Stage NSCLC
Status:
Completed
Trial end date:
2007-05-01
Target enrollment:
Participant gender:
Summary
To see the efficacy of using chemotherapies alternatively (carboplatin and gemcitabine
alternating with carboplatin and taxol) for pts with stage IIIB (nonresectable and stage IV
NSCLC.